HIV-1 inhibition in cells with CXCR4 mutant genome created by CRISPR-Cas9 and piggyBac recombinant technologies
Author:
Publisher
Springer Science and Business Media LLC
Subject
Multidisciplinary
Link
http://www.nature.com/articles/s41598-018-26894-4.pdf
Reference45 articles.
1. Dalgleish, A. G. et al. The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus. Nature 312, 763–767 (1984).
2. Mild, M. et al. Differences in molecular evolution between switch (R5 to R5X4/X4-tropic) and non-switch (R5-tropic only) HIV-1 populations during infection. Infection, Genetics and Evolution 10, 356–364 (2010).
3. Combadiere, C., Ahuja, S. K., Tiffany, H. L. & Murphy, P. M. Cloning and functional expression of CC CKR5, a human monocyte CC chemokine receptor selective for MIP-1 (alpha), MIP-1 (beta), and RANTES. Journal of leukocyte biology 60, 147–152 (1996).
4. Bleul, C. C., Farzan, M., Choe, H. & Parolin, C. The lymphocyte chemoattractant SDF-1 is a ligand for LESTR/fusin and blocks HIV-1 entry. Nature 382, 829 (1996).
5. Connor, R. I., Sheridan, K. E., Ceradini, D., Choe, S. & Landau, N. R. Change in coreceptor use correlates with disease progression in HIV-1–infected individuals. Journal of Experimental Medicine 185, 621–628 (1997).
Cited by 32 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Harnessing CRISPR technology for viral therapeutics and vaccines: from preclinical studies to clinical applications;Virus Research;2024-03
2. CRISPR/Cas-based diagnosis and treatment of infectious diseases;Molecular Medical Microbiology;2024
3. Genetically encoding multiple functionalities into extracellular vesicles for the targeted delivery of biologics to T cells;Nature Biomedical Engineering;2023-11-27
4. CRISPR/Cas9 Landscape: Current State and Future Perspectives;International Journal of Molecular Sciences;2023-11-08
5. Treatment of infectious diseases by <italic>in vivo</italic> gene editing;National Science Open;2023-08-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3